Halozyme Therapeutics reported $874.74M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amarin AMRN:US $ 0M 0M
Amgen AMGN:US $ 32782M 97M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 43.5M 1.09M
Baxter International BAX:US $ 6167M 79M
Cara Therapeutics CARA:US $ 0 0
Cytokinetics CYTK:US $ 139.14M 1.75M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Esperion Therapeutics ESPR:US $ 272.1M 404K
Halozyme Therapeutics HALO:US $ 874.74M 0.96M
Immunogen IMGN:US $ 1.1M 1M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Intrexon XON:US $ 0.36M 174.16M
IONIS PHARMACEUT IONS:US $ 1310.54M 370.12M
JAZZ PHA JAZZ:US $ 6744.3M 4642.65M
Mannkind MNKD:US $ 285.13M 45.46M
Minerva Neurosciences NERV:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Peregrine Pharmaceuticals PPHM:US $ 138.81M 41.86M
Rigel Pharmaceuticals RIGL:US $ 19.86M 0.02M
United Therapeutics UTHR:US $ 800M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M